Persistence Market Research
African Trypanosomiasis, also known as sleeping sickness disease, is one of the rarest infectious diseases that can affect one’s sleep pattern to a great extent. It is a parasitic disease caused by protozoan parasite of genus Trypanosoma and is carried by tsetse fly. There are two types of African Trypanosomiasis depending on the parasite: East African Trypanosomiasis caused by Trypanosoma brucei rhodesiense and West African Trypanosomiasis caused by Trypanosomiasis brucei gambiense. West African Trypanosomiasis causes a fatal infection which lasts for years while East African Trypanosomiasis has a limited range and lasts for several weeks. The symptoms associated with African Trypanosoniasis vary from one stage to another. There are two stages which are as follows:
African Trypanosomiasis can be diagnosed by examining the blood samples, bone marrow, lymph node fluid, cerebrospinal fluid or lymph node aspirate of the affected individual. However, the card agglutination test (CATT) is a useful test for the detection of trympanosome specific antibodies in blood, serum or plasma. CATT is a field and laboratory test usually applied for mass screening to detect African Trypanosoniasis. Moreover, three surgical tests are available for the detection of the parasite, namely, micro-CATT, wb-CATT, and wb-LATEX.
Based on the type of treatment, African Trypanosomiasis market can be segmented as follows:
According to WHO, 25,000 new cases of both East and West African Trypanosomiasis are reported each year globally. African Trypanosomiasis is primarily found in subtropical and equatorial Africa. The major driving factors for the growth of the African Trypanosomiasis market in this region are constantly growing number of poor population in East African, prevalence of unhygienic environment, rapid pace of technological advancement in the field of African Trypanosomiasis therapeutics, increasing number of population to opt for healthy lifestyle and the overall growing diagnostic and therapeutic market. On the other hand, the huge cost of drugs involved in the treatment of African Trypanosomiasis and difficulty in availability of these medications would most likely impede the growth of this market. Geographically, the African Trypanosomiasis market can be segmented into four major segments: North America, Europe, Asia-Pacific and rest of the world (RoW). Some of the top market players of the African Trypanosomiasis market are Sanofi, Genzyme Corporation, D-Pharm Ltd., aRigen Pharmaceuticals, Inc., Immtech Pharmaceuticals, Inc., Anacor Pharmaceuticals, Inc. and many others.
MRR.BIZ has been compiled in-depth market research data in the report after exhaustive primary and secondary research. Our team of able, experienced in-house analysts has collated the information through personal interviews and study of industry databases, journals, and reputable paid sources.
The report provides the following information:
The main aim of the report is to:
MRR.BIZ is a leading provider of strategic market research. Our vast repository consists research reports, data books, company profiles, and regional market data sheets. We regularly update the data and analysis of a wide-ranging products and services around the world. As readers, you will have access to the latest information on almost 300 industries and their sub-segments. Both large Fortune 500 companies and SMEs have found those useful. This is because we customize our offerings keeping in mind the specific requirements of our clients.